Mathematical Biology Models of Parkinson's Disease

Parkinsons disease (PD) is a progressive neurodegenerative disease with substantial and growing socio‐economic burden. In this multifactorial disease, aging, environmental, and genetic factors contribute to neurodegeneration and dopamine (DA) deficiency in the brain. Treatments aimed at DA restoration provide symptomatic relief, however, no disease modifying treatments are available, and PD remains incurable to date. Mathematical modeling can help understand such complex multifactorial neurological diseases. We review mathematical modeling efforts in PD with a focus on mechanistic models of pathogenic processes. We consider models of α‐synuclein (Asyn) aggregation, feedbacks among Asyn, DA, and mitochondria and proteolytic systems, as well as pathology propagation through the brain. We hope that critical understanding of existing literature will pave the way to the development of quantitative systems pharmacology models to aid PD drug discovery and development.

[1]  Eberhard O Voit,et al.  Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals , 2009, Synapse.

[2]  Michael Weiner,et al.  Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease. , 2015, Cell reports.

[3]  Suneil K. Kalia,et al.  Emerging disease‐modifying strategies targeting α‐synuclein for the treatment of Parkinson's disease , 2018, British journal of pharmacology.

[4]  J. Agar,et al.  Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth. , 2008, Biochemistry.

[5]  V. Sossi,et al.  Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. , 2009, Brain : a journal of neurology.

[6]  John P. Lowry,et al.  An integrative dynamic model of brain energy metabolism using in vivo neurochemical measurements , 2009, Journal of Computational Neuroscience.

[7]  M. Weiner,et al.  A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.

[8]  Rafal Bogacz,et al.  Computational Models Describing Possible Mechanisms for Generation of Excessive Beta Oscillations in Parkinson’s Disease , 2015, PLoS Comput. Biol..

[9]  Alexander K. Buell,et al.  Mutations associated with familial Parkinson’s disease alter the initiation and amplification steps of α-synuclein aggregation , 2016, Proceedings of the National Academy of Sciences.

[10]  V. Sossi,et al.  The Nature of Progression in Parkinson’s Disease: An Application of Non-Linear, Multivariate, Longitudinal Random Effects Modelling , 2013, PloS one.

[11]  Kim Sneppen,et al.  Modeling proteasome dynamics in Parkinson's disease , 2009, Physical biology.

[12]  Richard H. Middleton,et al.  A single compartment model of pacemaking in dissasociated Substantia nigra neurons , 2013, Journal of Computational Neuroscience.

[13]  Samik Ghosh,et al.  Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map , 2013, Molecular Neurobiology.

[14]  Efstathios D. Gennatas,et al.  Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.

[15]  D. Calvetti,et al.  Uncertainty quantification in flux balance analysis of spatially lumped and distributed models of neuron–astrocyte metabolism , 2016, Journal of mathematical biology.

[16]  D. Krainc,et al.  α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies , 2017, Nature Medicine.

[17]  D. Mann,et al.  Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. , 2008, Brain : a journal of neurology.

[18]  D. Calvetti,et al.  A spatially distributed computational model of brain cellular metabolism. , 2015, Journal of theoretical biology.

[19]  M. Duchen,et al.  Crosstalk between Lysosomes and Mitochondria in Parkinson's Disease , 2017, Front. Cell Dev. Biol..

[20]  P. Brundin,et al.  Prying into the Prion Hypothesis for Parkinson's Disease , 2017, The Journal of Neuroscience.

[21]  C. Dobson,et al.  Nucleation-conversion-polymerization reactions of biological macromolecules with prenucleation clusters. , 2014, Physical review. E, Statistical, nonlinear, and soft matter physics.

[22]  Carole J. Proctor,et al.  An in silico model of the ubiquitin-proteasome system that incorporates normal homeostasis and age-related decline , 2007, BMC Systems Biology.

[23]  P. Wellstead,et al.  Continuous real-time in vivo measurement of cerebral nitric oxide supports theoretical predictions of an irreversible switching in cerebral ROS after sufficient exposure to external toxins. , 2013, Journal of Parkinson's disease.

[24]  P. Nagabhushan,et al.  Mathematical approach to understand the kinetics of α-synuclein aggregation: Relevance to Parkinson's disease , 2008, Comput. Biol. Medicine.

[25]  Sébastien Ourselin,et al.  Computational modelling of pathogenic protein spread in neurodegenerative diseases , 2018, PloS one.

[26]  K. Kieburtz,et al.  A review of disease progression models of Parkinson's disease and applications in clinical trials , 2016, Movement disorders : official journal of the Movement Disorder Society.

[27]  E. Bézard,et al.  Alpha‐synuclein propagation: New insights from animal models , 2016, Movement disorders : official journal of the Movement Disorder Society.

[28]  Sylvie Retout,et al.  Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson’s Disease Patients , 2017, Pharmaceutical Research.

[29]  Lama M Chahine,et al.  Blood-based biomarkers for Parkinson's disease. , 2014, Parkinsonism & related disorders.

[30]  R. Finke,et al.  Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. , 2009, Biochimica et biophysica acta.

[31]  L. Clare,et al.  Cognitive reserve in Parkinson's disease: a systematic review and meta-analysis. , 2014, Parkinsonism & related disorders.

[32]  Yashar Sarbaz,et al.  A review of presented mathematical models in Parkinson’s disease: black- and gray-box models , 2015, Medical & Biological Engineering & Computing.

[33]  J. Jankovic,et al.  Functional decline in Parkinson disease. , 2001, Archives of neurology.

[34]  Carole J. Proctor,et al.  Modelling the Role of UCH-L1 on Protein Aggregation in Age-Related Neurodegeneration , 2010, PloS one.

[35]  Tuomas P. J. Knowles,et al.  Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading , 2016, Proceedings of the National Academy of Sciences.

[36]  Andreas Zell,et al.  Parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein , 2013, BMC Neuroscience.

[37]  Christopher M. Dobson,et al.  Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein , 2012, Cell.

[38]  Alexander K. Buell,et al.  The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation. , 2014, Journal of the American Chemical Society.

[39]  Eberhard O. Voit,et al.  Biochemical Systems Theory: A Review , 2013 .

[40]  H. Braak,et al.  Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered , 2006, Movement disorders : official journal of the Movement Disorder Society.

[41]  N. Bresolin,et al.  Brain Mitochondria, Aging, and Parkinson’s Disease , 2018, Genes.

[42]  S. Wieser,et al.  Social Costs of Iron Deficiency Anemia in 6–59-Month-Old Children in India , 2015, PloS one.

[43]  H. Nijhout,et al.  Theoretical Biology and Medical Modelling Open Access Homeostatic Mechanisms in Dopamine Synthesis and Release: a Mathematical Model , 2022 .

[44]  Jianhua Zhang,et al.  Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease , 2018, Journal of neurochemistry.

[45]  G. Porenta A computer model of neuronal pathways in the basal ganglia. , 1986, Computer methods and programs in biomedicine.

[46]  R. Chung,et al.  Potential Modes of Intercellular α-Synuclein Transmission , 2017, International journal of molecular sciences.

[47]  R. Finke,et al.  Sigmoidal Nucleation and Growth Curves Across Nature Fit by the Finke–Watzky Model of Slow Continuous Nucleation and Autocatalytic Growth: Explicit Formulas for the Lag and Growth Times Plus Other Key Insights , 2017 .

[48]  L. Kuhn,et al.  Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children , 2018, PloS one.

[49]  I. Kuznetsov,et al.  Mathematical models of α-synuclein transport in axons , 2016, Computer methods in biomechanics and biomedical engineering.

[50]  D. Mann,et al.  Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies , 2012, Neurobiology of Disease.

[51]  Raymond J. Dolan,et al.  Alterations in Brain Connectivity Underlying Beta Oscillations in Parkinsonism , 2011, PLoS Comput. Biol..

[52]  A. Duncan,et al.  Noise-induced multistability in chemical systems: Discrete versus continuum modeling. , 2014, Physical review. E, Statistical, nonlinear, and soft matter physics.

[53]  Michele Vendruscolo,et al.  Molecular mechanisms of protein aggregation from global fitting of kinetic models , 2016, Nature Protocols.

[54]  Elodie Marcon,et al.  Orthosteric Binding of ρ-Da1a, a Natural Peptide of Snake Venom Interacting Selectively with the α1A-Adrenoceptor , 2013, PloS one.

[55]  C. Dobson,et al.  Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation. , 2015, Nature chemical biology.

[56]  Robert L. Green,et al.  A pragmatic approach to biochemical systems theory applied to an α-synuclein-based model of Parkinson's disease , 2009, Journal of Neuroscience Methods.

[57]  M. Karlsson,et al.  Modeling a Composite Score in Parkinson’s Disease Using Item Response Theory , 2017, The AAPS Journal.

[58]  Elias S. Manolakos,et al.  In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis , 2014, BMC Systems Biology.

[59]  Michelle M. McCarthy,et al.  Striatal origin of the pathologic beta oscillations in Parkinson's disease , 2011, Proceedings of the National Academy of Sciences.

[60]  B. Hayete,et al.  Large-scale identification of clinical and genetic predictors of Parkinson’s disease motor progression in newly-diagnosed patients: a longitudinal cohort study and validation , 2017, The Lancet Neurology.

[61]  Vladimir S Fonov,et al.  Network connectivity determines cortical thinning in early Parkinson’s disease progression , 2017, Nature Communications.

[62]  A. Fallgatter,et al.  Alpha-Synuclein Levels in Blood Plasma Decline with Healthy Aging , 2015, PloS one.

[63]  G. Morfill,et al.  Observation of particle pairing in a two-dimensional plasma crystal. , 2013, Physical review. E, Statistical, nonlinear, and soft matter physics.

[64]  V. Baekelandt,et al.  Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease , 2018, Journal of immunology research.

[65]  J. Padiadpu,et al.  Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson’s disease: A dynamic model , 2007, Neuroscience.

[66]  P. Wellstead,et al.  Dynamic modelling of protein and oxidative metabolisms simulates the pathogenesis of Parkinson's disease. , 2012, IET systems biology.

[67]  C Laibe,et al.  The Impact of Mathematical Modeling in Understanding the Mechanisms Underlying Neurodegeneration: Evolving Dimensions and Future Directions , 2017, CPT: pharmacometrics & systems pharmacology.

[68]  María Suárez,et al.  Computational design of proteins with new functions , 2007, BMC Systems Biology.

[69]  R. Kream,et al.  Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders , 2018, Cellular and Molecular Neurobiology.

[70]  A. Hodgkin,et al.  A quantitative description of membrane current and its application to conduction and excitation in nerve , 1952, The Journal of physiology.

[71]  F. Gorin,et al.  Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson’s disease , 2006, Neuroscience.

[72]  A. Kuznetsov,et al.  What can trigger the onset of Parkinson's disease - A modeling study based on a compartmental model of α-synuclein transport and aggregation in neurons. , 2016, Mathematical biosciences.

[73]  D. Surmeier,et al.  Parkinson's Disease Is Not Simply a Prion Disorder , 2017, The Journal of Neuroscience.

[74]  Patrik Brundin,et al.  Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein , 2002, Nature Reviews Neuroscience.

[75]  Martin A. Nowak,et al.  Prion infection dynamics , 1998 .

[76]  P. Wellstead,et al.  Feedback motif for the pathogenesis of Parkinson's disease. , 2012, IET systems biology.

[77]  Sarika Jalan,et al.  The Human Body as a Super Network: Digital Methods to Analyze the Propagation of Aging , 2020, Frontiers in Aging Neuroscience.

[78]  Neil Benson,et al.  Systems Pharmacology: Bridging Systems Biology and Pharmacokinetics-Pharmacodynamics (PKPD) in Drug Discovery and Development , 2011, Pharmaceutical Research.

[79]  Michele Vendruscolo,et al.  Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. , 2011, The Journal of chemical physics.

[80]  Elise M. Braatz,et al.  A mathematical model of insulin resistance in Parkinson's disease , 2015, Comput. Biol. Chem..

[81]  R. Finke,et al.  Alpha-synuclein aggregation variable temperature and variable pH kinetic data: a re-analysis using the Finke-Watzky 2-step model of nucleation and autocatalytic growth. , 2009, Biophysical chemistry.

[82]  M. Cloutier,et al.  Metabolomics and In-Silico Analysis Reveal Critical Energy Deregulations in Animal Models of Parkinson’s Disease , 2013, PloS one.

[83]  Alberto J Espay,et al.  Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations , 2018, Movement disorders : official journal of the Movement Disorder Society.

[84]  Michael K. Bane,et al.  High-resolution Fourier-transform infrared spectroscopy of the v6 and Coriolis perturbation allowed v10 modes of ketenimine. , 2011 .

[85]  M. Jabbour,et al.  Chromatid recommensuration after segmental duplication , 2009, Theoretical Biology and Medical Modelling.

[86]  Eberhard O Voit,et al.  Rotenone and paraquat perturb dopamine metabolism: A computational analysis of pesticide toxicity. , 2014, Toxicology.

[87]  F. Oosawa,et al.  A theory of linear and helical aggregations of macromolecules. , 1962, Journal of molecular biology.

[88]  Mathieu Cloutier,et al.  An energy systems approach to Parkinson's disease , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[89]  Raymond J. Dolan,et al.  Anticipation and Choice Heuristics in the Dynamic Consumption of Pain Relief , 2015, PLoS Comput. Biol..

[90]  Michele Vendruscolo,et al.  Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. , 2011, The Journal of chemical physics.

[91]  Eberhard O. Voit,et al.  Computational Systems Analysis of Dopamine Metabolism , 2008, PloS one.